CD274 and neoplasm: In this context, multi-modal detection of PD-L1, such as PD-L1 protein, PD-L1 mRNA, and circulating PD-L1, might provide a comprehensive tumor profile and could allow for the determination of patients who are more suitable for ICI therapy [298].